NCT02657928 2021-10-26Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, or Endometrial CancerMayo ClinicPhase 2 Completed40 enrolled 15 charts